Historical Stock Price
MRSN historical stock prices picture
Mersana Therapeutics (MRSN) has the following price history information. Looking back at MRSN historical stock prices for the last five trading days, on April 17, 2024, MRSN opened at $3.78, traded as high as $3.83 and as low as $3.40, and closed at $3.52. Trading volume was a total of 2.60M shares. On April 18, 2024, MRSN opened at $3.44, traded as high as $3.56 and as low as $3.31, and closed at $3.34. Trading volume was a total of 1.27M shares. On April 19, 2024, MRSN opened at $3.31, traded as high as $3.35 and as low as $3.18, and closed at $3.25. Trading volume was a total of 2.39M shares. On April 22, 2024, MRSN opened at $3.30, traded as high as $3.30 and as low as $3.05, and closed at $3.15. Trading volume was a total of 1.80M shares. On April 23, 2024, MRSN opened at $3.17, traded as high as $3.32 and as low as $3.17, and closed at $3.21. Trading volume was a total of 1.88M shares.

MRSN Historical Stock Prices By Date:

MRSN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Mersana Therapeutics shares, starting with a $10,000 purchase of MRSN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/29/2017
End date: 04/23/2024
Start price/share: $13.52
End price/share: $3.21
Dividends collected/share: $0.00
Total return: -76.26%
Average Annual Total Return: -19.00%
Starting investment: $10,000.00
Ending investment: $2,375.16
Years: 6.82
Date Open High Low Close Volume
04/17/2024 $3.78 $3.83 $3.40 $3.52 2.60M
04/18/2024 $3.44 $3.56 $3.31 $3.34 1.27M
04/19/2024 $3.31 $3.35 $3.18 $3.25 2.39M
04/22/2024 $3.30 $3.30 $3.05 $3.15 1.80M
04/23/2024 $3.17 $3.32 $3.17 $3.21 1.88M
Mersana Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) for cancer patients. Co.'s platforms including Dolaflexin and Dolasynthen, deliver its auristatin DolaLock payload, as well as Immunosynthen, which delivers its stimulator of interferon genes (STING) agonist ImmunoLock payload. Co.'s product candidates include: upifitamab rilsodotin (UpRi), which is a Dolaflexin ADC targeting NaPi2b, an antigen expressed in ovarian cancer and other cancers; and XMT-1592, which is a Dolasynthen ADC targeting NaPi2b-expressing tumor cells.
Date Close
04/17/2024$3.52
04/18/2024$3.34
04/19/2024$3.25
04/22/2024$3.15
04/23/2024$3.21
MRSN is categorized under the Healthcare sector; below are some other companies in the same sector:

MRTX Historical Stock Prices
MSON Historical Stock Prices
MSTX Historical Stock Prices
MTEM Historical Stock Prices
MTNB Historical Stock Prices
MWIV Historical Stock Prices
MYG Historical Stock Prices
MYGN Historical Stock Prices
MYL Historical Stock Prices
MYND Historical Stock Prices

Also explore: MRSN shares outstanding history

Email EnvelopeFree MRSN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


MRSN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.